AMBEV S.A. current report, Q3 FY2023

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of August 2023, with the report signed on September 5, 2023. The filing is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory report on treasury share positions rather than a financial performance statement.

  • Treasury Shares (Common): 7,144,375
  • Treasury ADRs (Common): 0

Material Changes

There were no securities and derivatives operations conducted by the registrant during the month of August 2023. Consequently, there were no changes to the initial balance of outstanding shares in treasury.

  • Initial Balance: 7,144,375 Common Shares
  • Transactions: None
  • Final Balance: 7,144,375 Common Shares

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly limited to reporting the absence of trading activity in the company's own securities for the specified period.

Investor Verification Checklist

  • Verify that no treasury share transactions occurred in August 2023 as stated.
  • Confirm the total count of outstanding treasury shares remains at 7,144,375.
  • Note that this filing contains no financial performance data; refer to Form 20-F or quarterly earnings releases for revenue and profit metrics.